Literature DB >> 8164264

Structural features important for sigma 1 receptor binding.

R A Glennon1, S Y Ablordeppey, A M Ismaiel, M B el-Ashmawy, J B Fischer, K B Howie.   

Abstract

Two problems that have hampered sigma receptor research are (i) a lack of high-affinity agents and (ii) the recent identification of multiple populations of sigma receptors (i.e., sigma 1 and sigma 2 sites). Recently, several high-affinity sigma ligands have been identified, and the term superpotent sigma ligands has been coined to describe agents with Ki values of < 1 nM. We have previously shown that appropriately N-substituted phenylalkylamines bind at sigma receptors with high affinity. In the present investigation, we examine the structure-affinity relationships of these phenylalkylamine derivatives for sigma 1 binding and describe some of the first superpotent sigma 1 ligands. A binding model was developed to account for the structural features of the phenylalkylamines that appear to be important for the interaction of these agents with sigma 1 sites.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8164264     DOI: 10.1021/jm00034a020

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

1.  The sigma-1 receptor chaperone as an inter-organelle signaling modulator.

Authors:  Tsung-Ping Su; Teruo Hayashi; Tangui Maurice; Shilpa Buch; Arnold E Ruoho
Journal:  Trends Pharmacol Sci       Date:  2010-10-01       Impact factor: 14.819

2.  Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor.

Authors:  Erik Laurini; Valentina Dal Col; Maria Grazia Mamolo; Daniele Zampieri; Paola Posocco; Maurizio Fermeglia; Luciano Vio; Sabrina Pricl
Journal:  ACS Med Chem Lett       Date:  2011-08-27       Impact factor: 4.345

3.  New consensus multivariate models based on PLS and ANN studies of sigma-1 receptor antagonists.

Authors:  Aline A Oliveira; Célio F Lipinski; Estevão B Pereira; Kathia M Honorio; Patrícia R Oliveira; Karen C Weber; Roseli A F Romero; Alexsandro G de Sousa; Albérico B F da Silva
Journal:  J Mol Model       Date:  2017-10-02       Impact factor: 1.810

4.  Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents.

Authors:  Silvia Franchini; Pasquale Linciano; Giulia Puja; Annalisa Tait; Chiara Borsari; Nunzio Denora; Rosa Maria Iacobazzi; Livio Brasili; Claudia Sorbi
Journal:  ACS Med Chem Lett       Date:  2020-04-03       Impact factor: 4.345

5.  The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.

Authors:  Dominique Fontanilla; Molly Johannessen; Abdol R Hajipour; Nicholas V Cozzi; Meyer B Jackson; Arnold E Ruoho
Journal:  Science       Date:  2009-02-13       Impact factor: 47.728

6.  From α4β2 Nicotinic Ligands to the Discovery of σ1 Receptor Ligands: Pharmacophore Analysis and Rational Design.

Authors:  Li-Fang Yu; Han-Kun Zhang; Hendra Gunosewoyo; Alan P Kozikowski
Journal:  ACS Med Chem Lett       Date:  2012-12-13       Impact factor: 4.345

7.  Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 2: Introduction of cyclic substituents in position 4.

Authors:  José Luis Díaz; Jordi Corbera; Daniel Martínez; Magda Bordas; Cristina Sicre; Rosalia Pascual; Mª José Pretel; Ana Paz Marín; Ana Montero; Albert Dordal; Inés Alvarez; Carmen Almansa
Journal:  Medchemcomm       Date:  2017-04-20       Impact factor: 3.597

8.  Pyrazolo[3,4-d]pyrimidines as sigma-1 receptor ligands for the treatment of pain. Part 1: 4-acylamino derivatives.

Authors:  José Luis Díaz; Jordi Corbera; Rosa Cuberes; Montserrat Contijoch; Raquel Enrech; Sandra Yeste; Ana Montero; Albert Dordal; Xavier Monroy; Carmen Almansa
Journal:  Medchemcomm       Date:  2017-04-20       Impact factor: 3.597

Review 9.  Knocking Out Sigma-1 Receptors Reveals Diverse Health Problems.

Authors:  Simon Couly; Nino Goguadze; Yuko Yasui; Yuriko Kimura; Shao-Ming Wang; Nino Sharikadze; Hsiang-En Wu; Tsung-Ping Su
Journal:  Cell Mol Neurobiol       Date:  2020-10-23       Impact factor: 5.046

10.  Dipentylammonium Binds to the Sigma-1 Receptor and Protects Against Glutamate Toxicity, Attenuates Dopamine Toxicity and Potentiates Neurite Outgrowth in Various Cultured Cell Lines.

Authors:  James M Brimson; Stephen T Safrany; Heider Qassam; Tewin Tencomnao
Journal:  Neurotox Res       Date:  2018-03-27       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.